A detailed history of Miller Financial Services LLC transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Miller Financial Services LLC holds 22,000 shares of ADGI stock, worth $72,820. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,000
Holding current value
$72,820
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

BUY
N/A
22,000 New
22,000 $13.3 Million

Others Institutions Holding ADGI

About Adagio Therapeutics, Inc.


  • Ticker ADGI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,831,000
  • Market Cap $505M
  • Description
  • Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...
More about ADGI
Track This Portfolio

Track Miller Financial Services LLC Portfolio

Follow Miller Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Financial Services LLC with notifications on news.